SCHEMBL1563585

SCHEMBL1563585

Cc1cnc(O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL28224028 0.97
SCHEMBL4584646 0.80
SCHEMBL82304 0.80
Ammonia Solution, Strong SCHEMBL27508580 0.77
SCHEMBL31520440 0.77 UHRF1 (0.41)
Ethoxycarbonyl Group SCHEMBL27894074 0.77 POLB (0.34)
SCHEMBL10021907 0.69 CCR1 (0.41)
SCHEMBL5666185 0.67 UHRF1 (0.35)
SCHEMBL16848019 0.65
SCHEMBL19053655 0.65 NPC1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119009136-A Pyrazinyl eutectic electrolyte with wide electrochemical stability window, and preparation method and application thereof 中国科学院长春应用化学研究所 2024-11-22 CN claimed
JP-6345741-A None JP disclosed
EP-4647429-A1 PYRIDAZINONE HETEROCYCLIC COMPOUND MYOSIN II INHIBITOR AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2025-11-12 EP disclosed
US-12233062-B2 Heterocyclic derivatives useful as SHP2 inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2025-02-25 US disclosed
CN-119009136-A Pyrazinyl eutectic electrolyte with wide electrochemical stability window, and preparation method and application thereof 中国科学院长春应用化学研究所 2024-11-22 CN disclosed
US-20240285617-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-08-29 US disclosed
US-20240245681-A1 HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBO PHARMACEUTICATS CO LTD (CN) 2024-07-25 US disclosed
WO-2024146559-A1 PYRIDAZINONE HETEROCYCLIC COMPOUND MYOSIN II INHIBITOR AND USE THEREOF 西藏海思科制药有限公司 2024-07-11 WO disclosed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
US-20240116921-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN INC. 2024-04-11 US disclosed
US-5618821-A VIRICIDES, PICORNAVIRUS SANOFI, S.A. (FR) 1997-04-08 US disclosed
WO-1995031438-A1 THERAPEUTIC PHENOXYALKYLHETEROCYCLES SANOFI WINTHROP, INC. (US) 1995-11-23 WO disclosed
EP-0477829-B1 Microbiological process for the preparation of hydroxylated heterocyclic compounds LONZA AG (CH) 1995-06-28 EP disclosed
JP-H06345741-A PRODUCTION OF PYRAZINE DERIVATIVE KANEBO LTD 1994-12-20 JP disclosed
US-5284767-A Pyrazines or quinoxalines as the sole carbon, nitrogen and energy source LONZA LTD. (CH) 1994-02-08 US disclosed
US-5266482-A Biosynthesis LONZA LTD. (CH) 1993-11-30 US disclosed
US-5229278-A Hydroxylating a pyrazine or quinoxaline with a microorganism Rhodococcus or Arthrobacter LONZA LTD. (CH) 1993-07-20 US disclosed
US-5173412-A Converted with microorganism Agrobacterium LONZA, LTD. (CH) 1992-12-22 US disclosed
EP-0484908-A2 Microbiological process for the preparation of hydroxylated Pyrazinederivatives LONZA A.G. (CH) 1992-05-13 EP disclosed
EP-0477829-A2 Microbiological process for the preparation of hydroxylated heterocyclic compounds LONZA AG (CH) 1992-04-01 EP disclosed